鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/09/30 | 3,050 | 3,055 | 2,963 | 2,978 | -62 | -2% | 32,800 |
2020/09/29 | 3,050 | 3,050 | 2,967 | 3,040 | +10 | +0.3% | 33,800 |
2020/09/28 | 3,030 | 3,060 | 2,978 | 3,030 | +68 | +2.3% | 46,500 |
2020/09/25 | 2,956 | 2,996 | 2,921 | 2,962 | +28 | +1% | 58,600 |
2020/09/24 | 3,000 | 3,000 | 2,919 | 2,934 | -66 | -2.2% | 48,700 |
2020/09/23 | 3,030 | 3,030 | 2,911 | 3,000 | -5 | -0.2% | 61,100 |
2020/09/18 | 2,996 | 3,030 | 2,986 | 3,005 | +36 | +1.2% | 55,900 |
2020/09/17 | 2,970 | 2,977 | 2,884 | 2,969 | +8 | +0.3% | 35,700 |
2020/09/16 | 2,948 | 2,987 | 2,943 | 2,961 | +16 | +0.5% | 29,200 |
2020/09/15 | 2,940 | 2,947 | 2,911 | 2,945 | +23 | +0.8% | 19,100 |
2020/09/14 | 2,943 | 2,964 | 2,915 | 2,922 | +29 | +1% | 33,200 |
2020/09/11 | 2,879 | 2,895 | 2,852 | 2,893 | +42 | +1.5% | 43,000 |
2020/09/10 | 2,863 | 2,872 | 2,846 | 2,851 | +17 | +0.6% | 22,500 |
2020/09/09 | 2,849 | 2,849 | 2,799 | 2,834 | -33 | -1.2% | 32,900 |
2020/09/08 | 2,842 | 2,870 | 2,833 | 2,867 | +54 | +1.9% | 35,600 |
2020/09/07 | 2,764 | 2,813 | 2,764 | 2,813 | +49 | +1.8% | 29,300 |
2020/09/04 | 2,750 | 2,779 | 2,741 | 2,764 | -27 | -1% | 26,700 |
2020/09/03 | 2,804 | 2,840 | 2,750 | 2,791 | +33 | +1.2% | 33,400 |
2020/09/02 | 2,794 | 2,798 | 2,752 | 2,758 | -15 | -0.5% | 23,400 |
2020/09/01 | 2,817 | 2,840 | 2,746 | 2,773 | +14 | +0.5% | 47,200 |
2020/08/31 | 2,800 | 2,823 | 2,759 | 2,759 | -22 | -0.8% | 38,400 |
2020/08/28 | 2,881 | 2,881 | 2,776 | 2,781 | -55 | -1.9% | 51,300 |
2020/08/27 | 2,880 | 2,880 | 2,812 | 2,836 | -40 | -1.4% | 30,500 |
2020/08/26 | 2,922 | 2,924 | 2,870 | 2,876 | -45 | -1.5% | 22,200 |
2020/08/25 | 2,940 | 2,942 | 2,895 | 2,921 | +1 | ±0% | 34,200 |
2020/08/24 | 2,975 | 2,975 | 2,888 | 2,920 | -38 | -1.3% | 29,800 |
2020/08/21 | 2,880 | 2,958 | 2,857 | 2,958 | +76 | +2.6% | 78,000 |
2020/08/20 | 2,955 | 2,980 | 2,868 | 2,882 | -128 | -4.3% | 75,800 |
2020/08/19 | 3,040 | 3,050 | 3,005 | 3,010 | -5 | -0.2% | 10,700 |
2020/08/18 | 2,994 | 3,040 | 2,950 | 3,015 | +27 | +0.9% | 29,800 |
2020/08/17 | 3,075 | 3,075 | 2,988 | 2,988 | -82 | -2.7% | 35,300 |
2020/08/14 | 3,155 | 3,155 | 3,040 | 3,070 | -45 | -1.4% | 42,000 |
2020/08/13 | 3,090 | 3,120 | 3,060 | 3,115 | +55 | +1.8% | 42,100 |
2020/08/12 | 3,005 | 3,075 | 2,995 | 3,060 | +55 | +1.8% | 44,500 |
2020/08/11 | 3,010 | 3,050 | 2,988 | 3,005 | +13 | +0.4% | 48,800 |
2020/08/07 | 3,085 | 3,085 | 2,987 | 2,992 | -108 | -3.5% | 79,600 |
2020/08/06 | 3,080 | 3,125 | 3,070 | 3,100 | +5 | +0.2% | 41,300 |
2020/08/05 | 3,130 | 3,155 | 3,075 | 3,095 | -80 | -2.5% | 51,700 |
2020/08/04 | 3,300 | 3,320 | 3,155 | 3,175 | -130 | -3.9% | 65,100 |
2020/08/03 | 3,365 | 3,365 | 3,235 | 3,305 | -75 | -2.2% | 69,700 |
2020/07/31 | 3,475 | 3,490 | 3,350 | 3,380 | -150 | -4.2% | 54,700 |
2020/07/30 | 3,450 | 3,530 | 3,440 | 3,530 | +80 | +2.3% | 54,700 |
2020/07/29 | 3,535 | 3,535 | 3,440 | 3,450 | -40 | -1.1% | 40,300 |
2020/07/28 | 3,525 | 3,640 | 3,480 | 3,490 | -10 | -0.3% | 61,300 |
2020/07/27 | 3,465 | 3,500 | 3,435 | 3,500 | +35 | +1% | 53,300 |
2020/07/22 | 3,430 | 3,505 | 3,400 | 3,465 | +35 | +1% | 78,700 |
2020/07/21 | 3,465 | 3,465 | 3,375 | 3,430 | ±0 | ±0% | 41,200 |
2020/07/20 | 3,395 | 3,490 | 3,325 | 3,430 | +130 | +3.9% | 112,700 |
2020/07/17 | 3,325 | 3,330 | 3,245 | 3,300 | +5 | +0.2% | 48,700 |
2020/07/16 | 3,380 | 3,415 | 3,265 | 3,295 | -40 | -1.2% | 83,000 |
1201~
1250
件表示中 / 3769件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
ペプチド | 154,000円 | +5.0% | +1.5% | 0.00% | 13.18倍 | 3.71倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 426,500円 | +3.6% | - | 2.81% | 14.37倍 | 0.85倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サンバイオ | 239,600円 | - | - | 0.00% | - | 110.98倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 385,500円 | -6.4% | -71.8% | 4.93% | 42.93倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム